Extract from the Ramsay Santé press release
Article 51" experiments:
Ramsay Santé launches two innovative devices in oncology
- Within the framework of the national "Article 51" scheme, which allows for the experimentation of new health organisations based on new financing methods, Ramsay Santé, one of the European leaders in private hospitalisation and primary care, is launching two experiments in cancerology.
- The first, developed at the Lille Metropole Cancer Institute, concerns the implementation of an adapted physical activity programme (combining face-to-face, distance learning and digital solutions) as part of a post-cancer pathway for a total of 500 patients over 3 years, starting from the date of the first patient included.
- The second, called METIS CONNECT and developed at the Jean Mermoz Cancer Institute in Lyon, concerns the implementation of digital monitoring of digestive cancer patients between chemotherapy treatments.
- Ramsay Santé is the leading private player in cancer research in France and has made the fight against cancer a priority, which is particularly evident in its 12 cancer institutes (7 generalists and 5 specialising in breast cancer).
METIS CONNECT: a digital monitoring system for patients with digestive cancer at the Jean Mermoz Cancer Institute between chemotherapy treatments
Coordination of care is a major issue in the quality of cancer care. However, in practice, the transmission of information between the various health care providers is very complicated. The patient is often solely responsible for transmitting information relating to his or her care pathway, which can have serious consequences for his or her care (difficulties in sharing information in the patient file, unsecured information circuit, delayed access and sometimes retrospective collection, qualitative and quantitative loss of information, etc.).
Ramsay Santé, aware of this challenge, created in 2013, in its cancer institutes, the job of nurse coordinator in charge of accompanying the most vulnerable patients and their relatives throughout their journey, including after treatment.